Physician profile
Boqing Chen
NPI 1649291410
$6,934.90
in general payments reported to CMS, 2019-2025
40 companies · $669 in 2025
The $669 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,372 · 2020: $271 · 2021: $750 · 2022: $704 · 2023: $1,522 · 2024: $647 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,454 · Travel and Lodging: $304 · Education: $79.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,454.04 |
| Travel and Lodging | $304.01 |
| Education | $79.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $1,494.62 | 2019 | |
| Abbott Laboratories | $1,056.15 | 2019-2025 | Proclaim, Eterna, Infinity |
| Collegium Pharmaceutical, INC. | $648.25 | 2019-2025 | Belbuca, Xtampza |
| Curonix LLC | $581.01 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $398.34 | 2019-2024 | |
| Medtronic, INC. | $329.27 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Closurefast |
| Daiichi Sankyo INC. | $281.01 | 2019 | |
| Saluda Medical Americas, INC. | $237.92 | 2025 | Evoke |
| Vertos Medical, INC. | $218.71 | 2022-2024 | Mild Device Kit |
| Kowa Pharmaceuticals America, INC. | $162.23 | 2022-2023 | Seglentis |
| Arbor Pharmaceuticals, INC. | $156.35 | 2020-2021 | |
| Biotronik Nro, INC. | $146.92 | 2023-2025 | Prospera, Biotronik |
| Spr Therapeutics, INC | $144.59 | 2023-2024 | Sprint Pns System |
| Si-Bone, INC. | $136.69 | 2019-2024 | |
| Pfizer INC. | $127.20 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boqing Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.